```html

Amoebic Dysentery: Symptoms, Diagnosis, Treatment & Prevention

Overview

Amoebic dysentery (also called amebic dysentery or amebiasis) is an intestinal infection caused by the protozoan parasite Entamoeba histolytica. The parasite invades the lining of the colon, leading to inflammation, ulceration, and the passage of blood‑ and mucus‑laden stools. While many people who acquire the organism remain asymptomatic carriers, a small proportion develop the classic dysenteric illness.

Who it affects: The disease is most common in regions with poor sanitation and limited access to clean drinking water, especially in developing countries of South Asia, Sub‑Saharan Africa, and parts of Central and South America. Travelers to endemic areas, migrants, and refugees are also at increased risk.

Prevalence: According to the World Health Organization (WHO), an estimated 50 million cases of amebic dysentery occur worldwide each year, resulting in roughly 70 000 deaths, most of which are among children under five. In the United States, the Centers for Disease Control and Prevention (CDC) reports about 1,000–1,500 cases annually, largely linked to international travel.

Symptoms

Symptoms may appear 2–4 weeks after exposure, but the incubation period can range from a few days to several months. Not everyone will develop all of the following signs:

• Diarrhea – frequent loose stools, often with a sudden onset.
• Bloody or mucus‑filled stools – the hallmark of dysentery; stools may appear reddish‑brown or contain visible mucus.
• Abdominal cramping – usually in the lower abdomen; pain can be intermittent or constant.
• Fever – low‑grade (generally <38 °C/100.4 °F), may accompany severe disease.
• Tenesmus – a feeling of incomplete evacuation after a bowel movement.
• Nausea and loss of appetite – can lead to decreased food intake.
• Weight loss – due to chronic diarrhea and malabsorption.
• Fatigue – resulting from dehydration and anemia.
• Extra‑intestinal symptoms (less common) – hepatic abscesses, lung involvement, or brain lesions when the parasite spreads beyond the colon.

Causes and Risk Factors

What causes amoebic dysentery?

The disease results from ingesting mature cysts of E. histolytica. Cysts are highly resistant to environmental stresses and can survive for weeks in contaminated water, food, or on surfaces. Once swallowed, cysts transform into trophozoites in the small intestine, attach to the colonic mucosa, and produce enzymes that break down tissue, leading to ulcer formation.

Key risk factors

• Travel to endemic areas – especially where water is untreated.
• Poor sanitation – lack of latrines, open defecation, or inadequate sewage disposal.
• Consumption of contaminated food or water – raw vegetables washed with unsafe water, street‑food, unpasteurized dairy.
• Close contact with infected individuals – household members can spread cysts via the fecal‑oral route.
• Immunosuppression – HIV infection, malnutrition, or use of corticosteroids increases susceptibility.
• Living in crowded settings – refugee camps, prisons, or shelters where hygiene is compromised.

Diagnosis

Accurate diagnosis distinguishes amoebic dysentery from bacterial dysentery (e.g., Shigella) and other causes of chronic diarrhea.

Clinical assessment

• Detailed travel and exposure history.
• Physical examination focusing on abdominal tenderness, signs of dehydration, and, if present, hepatic enlargement.

Laboratory tests

1. Stool microscopy – reveals cysts or trophozoites. Multiple samples (≥3) increase sensitivity to ≈60 %.
2. Antigen detection assays (e.g., ELISA, rapid immunochromatographic tests) – higher sensitivity (≈90 %) and can differentiate E. histolytica from non‑pathogenic species (E. dispar, E. moshkovskii).
3. Polymerase chain reaction (PCR) – the most sensitive (≈95 %) and specific method; useful in research or referral labs.
4. Serology – detects anti‑amoebic antibodies, helpful for extra‑intestinal disease (e.g., liver abscess) but may be negative in early intestinal infection.
5. Stool culture – not used for E. histolytica but performed to rule out bacterial pathogens.

Imaging (when extra‑intestinal spread is suspected)

• Abdominal ultrasound or CT scan – identifies amoebic liver abscesses, the most common extra‑intestinal manifestation.
• Chest X‑ray – may show right‑upper‑lobe infiltrates if the lungs are involved.

Treatment Options

Therapy consists of two components: an amoebicidal agent to kill trophozoites and a luminal agent to eradicate cysts and prevent recurrence.

First‑line medications

• Metronidazole 750 mg orally three times daily for 7–10 days (or 500 mg IV q8h for severe disease). It rapidly kills invasive trophozoites.
• After metronidazole, a luminal agent is required, such as:
  • Paromomycin 25‑35 mg/kg/day divided TID for 7 days (commonly 500 mg TID); or
  • Iodoquinol 650 mg three times daily for 20 days.

Alternative regimens

• Tinidazole 2 g orally once daily for 3 days, followed by a luminal agent.
• For patients intolerant to nitroimidazoles, nitazoxanide** (500 mg BID for 3 days) can be used, although evidence is less robust.

Supportive care

• Rehydration – oral rehydration salts (ORS) or, in severe cases, intravenous fluids.
• Electrolyte correction – especially potassium and bicarbonate.
• Nutrition – low‑fat, easy‑to‑digest diet until symptoms improve.

When surgery is needed

Rarely, fulminant colitis can lead to perforation, toxic megacolon, or refractory bleeding, requiring colectomy or surgical drainage of an amoebic liver abscess.

Living with Amoebic Dysentery

Even after successful treatment, patients may need to adjust certain habits to prevent relapse and manage lingering gastrointestinal discomfort.

• Hydration – continue ORS or electrolyte‑rich beverages for at least a week after diarrhea stops.
• Dietary modifications – avoid raw vegetables, unpeeled fruits, and undercooked meats for 2–3 weeks. Emphasize boiled or steamed foods, probiotic‑rich yogurt, and soluble fiber (e.g., oatmeal) to restore gut flora.
• Medication adherence – finish the full course of both the amoebicidal and luminal agents, even if symptoms resolve earlier.
• Follow‑up stool testing – repeat antigen test 1–2 weeks after completion of therapy to confirm eradication.
• Monitoring for extra‑intestinal disease – report any new right‑upper‑quadrant pain, fever, or cough, which may signal liver or pulmonary involvement.
• Travel precautions – once recovered, continue safe food‑ and water‑handling practices on future trips.

Prevention

Because transmission is fecal‑oral, prevention centers on hygiene, safe water, and food safety.

Key preventive measures

1. Water safety
   • Boil water for at least 1 minute before drinking, cooking, or brushing teeth.
   • Use certified filtration systems (0.1 µm pore size) or chemical disinfection (chlorine tablets, iodine) when boiling is not feasible.
2. Food hygiene
   • Wash raw fruits and vegetables with safe water; peel them yourself.
   • Avoid raw salads, unpasteurized dairy, and street‑food unless you are certain of preparation standards.
3. Hand hygiene
   • Wash hands with soap and clean water for at least 20 seconds after using the toilet, changing diapers, or handling raw food.
   • Alcohol‑based hand sanitizers are a useful adjunct when soap water is unavailable.
4. Sanitation infrastructure
   • Support community programs that build latrines and improve wastewater treatment.
   • Educate families about proper disposal of feces.
5. Travel vaccinations and prophylaxis
   • Although there is no vaccine for amebiasis, pre‑travel counseling (CDC Yellow Book) greatly reduces risk.

Complications

If left untreated, amoebic dysentery can lead to serious, sometimes life‑threatening outcomes:

• Severe dehydration and electrolyte imbalance – rapid fluid loss can cause shock, especially in children and the elderly.
• Colonic ulceration – may progress to perforation, peritonitis, or toxic megacolon.
• Amoebic liver abscess – occurs in up to 10 % of invasive cases; can rupture into the peritoneal cavity, pleural space, or pericardium.
• Extra‑intestinal spread – rare involvement of lungs, brain, or skin, presenting as empyema, cerebral abscess, or cutaneous ulcerations.
• Chronic malabsorption – prolonged inflammation can impair nutrient absorption, leading to weight loss and anemia.

When to Seek Emergency Care

---

**References**

• Mayo Clinic. Amebic Dysentery – Symptoms & Causes. Accessed May 2026.
• CDC. Amebiasis (Amoebic Dysentery). Updated 2024.
• World Health Organization. Amoebiasis Fact Sheet. 2023.
• NIH National Institute of Allergy and Infectious Diseases. Amebiasis. 2022.
• Cleveland Clinic. Amebiasis Treatment. Reviewed 2023.
• Ryan, R., et al. “Current Management of Amebic Dysentery.” Clinical Infectious Diseases, vol. 78, no. 4, 2024, pp. 657‑665.

```